Picture of IDL Diagnostics AB (publ) logo

IDLDX — IDL Diagnostics AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Brief: Arocell Q2 Loss After Financial Items Widens To SEK 16.0 Million

Aug 17 (Reuters) - AroCell AB (publ)  AROC.ST :
    * AROCELL AB (PUBL) INTERIM REPORT JANUARY 1ST TO JUNE 30TH,
2022
    * Q2 NET SALES AMOUNTED TO 6,349 (30) KSEK
    * Q2 PROFIT AFTER FINANCIAL ITEMS AMOUNTED TO -16,016
(-6,727)
KSEK
    * Q2 CASH FLOW FROM OPERATING ACTIVITIES FOR PERIOD AMOUNTED
TO
-1,397 (-5,185) KSEK

Source text for Eikon:  ID:nMFN3QgJry 
Further company coverage:  AROC.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on IDL Diagnostics AB (publ)

See all news